NDAORALCAPSULE, EXTENDED RELEASE
Approved
Dec 1989
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed Yesterday · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
PINDAC (pinacidil) is an oral extended-release capsule approved in 1989 as a small-molecule vasodilator. The exact indication is not specified in available data, but pinacidil is historically used for hypertension management. Its mechanism involves opening ATP-sensitive potassium channels, reducing peripheral vascular resistance.
LOE Approaching
Product is in advanced lifecycle stage with competitive pressure at 30%, signaling a contracting team focused on cost management and lifecycle extension rather than growth initiatives.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on PINDAC offers limited career growth opportunities given its LOE-approaching status and zero linked job openings; roles are predominantly defensive (market access, cost management, sales optimization). This is a stabilization assignment suited for experienced professionals managing decline rather than those seeking launch experience or rapid promotion.
Brand Manager (Lifecycle Management)
Worked on PINDAC at PleoPharma? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.